Natera, Inc. (NASDAQ:NTRA – Get Free Report) CEO Steven Leonard Chapman sold 4,084 shares of Natera stock in a transaction on Monday, April 29th. The stock was sold at an average price of $93.14, for a total value of $380,383.76. Following the transaction, the chief executive officer now directly owns 226,235 shares of the company’s […]
Natera (NASDAQ:NTRA – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday. NTRA has been the subject of several other reports. Canaccord Genuity Group boosted their price objective on Natera from $87.00 to $100.00 and gave the stock […]
Natera, Inc. (NASDAQ:NTRA – Get Free Report) CFO Michael Burkes Brophy sold 1,238 shares of Natera stock in a transaction on Monday, April 29th. The stock was sold at an average price of $93.14, for a total value of $115,307.32. Following the sale, the chief financial officer now directly owns 69,408 shares of the company’s […]
International Assets Investment Management LLC raised its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 6,007.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,329 shares of the medical research company’s stock after purchasing an additional 7,209 […]
Jennison Associates LLC bought a new position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 212,811 shares of the medical research company’s stock, valued at approximately $13,330,000. Jennison Associates […]